P

Inventor

GRAY NATHANAEL S

US141 patents
⚠️ This page may combine multiple inventors who share the name “GRAY NATHANAEL S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DANA FARBER CANCER INST INC

27 patents
US10550121B2Feb 4, 2020

Inhibitors of cyclin-dependent kinases

DANA FARBER CANCER INST INC15 citations94
US9862688B2Jan 9, 2018

Hydrophobically tagged janus kinase inhibitors and uses thereof

DANA FARBER CANCER INST INC22 citations94
US9676792B2Jun 13, 2017

Pyrimido-diazepinone compounds and methods of treating disorders

DANA FARBER CANCER INST INC12 citations91
US11325910B2May 10, 2022

Inhibitors of cyclin-dependent kinases

DANA FARBER CANCER INST INC8 citations86
US10017477B2Jul 10, 2018

Janus kinase inhibitors and uses thereof

DANA FARBER CANCER INST INC20 citations86
US11306070B2Apr 19, 2022

Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof

DANA FARBER CANCER INST INC8 citations84
US10975058B2Apr 13, 2021

Imidazolyl kinase inhibitors and uses thereof

DANA FARBER CANCER INST INC6 citations84
US10870651B2Dec 22, 2020

Inhibitors of cyclin-dependent kinase 7 (CDK7)

DANA FARBER CANCER INST INC9 citations84
US10457691B2Oct 29, 2019

Macrocyclic kinase inhibitors and uses thereof

DANA FARBER CANCER INST INC9 citations84
US10287268B2May 14, 2019

Imidazolyl kinase inhibitors and uses thereof

DANA FARBER CANCER INST INC11 citations84
US9464091B2Oct 11, 2016

Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders

DANA FARBER CANCER INST INC5 citations84
US10265321B2Apr 23, 2019

Uses of salt-inducible kinase (SIK) inhibitors

DANA FARBER CANCER INST INC10 citations83
US10112957B2Oct 30, 2018

Thiazolyl-containing compounds for treating proliferative diseases

DANA FARBER CANCER INST INC5 citations83
US9908872B2Mar 6, 2018

Methods to treat lymphoplasmacytic lymphoma

DANA FARBER CANCER INST INC6 citations83
US9856223B2Jan 2, 2018

Methods to treat lymphoplasmacytic lymphoma

DANA FARBER CANCER INST INC6 citations83
US9695172B2Jul 4, 2017

Diazepane derivatives and uses thereof

DANA FARBER CANCER INST INC13 citations83
US10233157B2Mar 19, 2019

SIK inhibitor for use in a method of treating an inflammatory and/or immune disorder

DANA FARBER CANCER INST INC9 citations82
US10925967B2Feb 23, 2021

Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use

DANA FARBER CANCER INST INC4 citations81
US12098154B2Sep 24, 2024

Inhibitors of cyclin-dependent kinases

DANA FARBER CANCER INST INC1 citations73
US11932625B2Mar 19, 2024

Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof

DANA FARBER CANCER INST INC3 citations73
US11826365B2Nov 28, 2023

Type II raf kinase inhibitors

DANA FARBER CANCER INST INC1 citations73
US10981903B2Apr 20, 2021

Inhibitors of c-Jun-N-terminal kinase (JNK)

DANA FARBER CANCER INST INC4 citations73
US10913744B2Feb 9, 2021

LRRK2 inhibitors and methods of making and using the same

DANA FARBER CANCER INST INC3 citations73
US10695346B2Jun 30, 2020

4,6-pyrimidinylene derivatives and uses thereof

DANA FARBER CANCER INST INC5 citations73
US10342798B2Jul 9, 2019

Fused bicyclic pyrimidine derivatives and uses thereof

DANA FARBER CANCER INST INC7 citations73
US10081639B2Sep 25, 2018

Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders

DANA FARBER CANCER INST INC2 citations73
US9701683B2Jul 11, 2017

Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders

DANA FARBER CANCER INST INC2 citations73

IRM LLC

9 patents

UNIV CALIFORNIA

4 patents

SCRIPPS RESEARCH INST

3 patents

GRAY NATHANAEL S

3 patents

BROAD INST INC

2 patents

NOVARTIS AG

1 patent

GATEKEEPER PHARMACEUTICALS INC

1 patent

Showing the top 50 of 141 patents by PatentIndex Score.